Delivery Order DEAM0376SF00034-DEAT0377EV70264
Award Date 9/23/77
Potential Completion Date 12/31/99
Potential Value Not listed
Funding Federal Agency
Not listed Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Not listed PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Non-Competitive Delivery Order
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
California, USA
Solicitation Procedures
Not listed
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amgen USA Inc. received a modification to its existing definitive contract with the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) to exercise option periods 3 and 4 and modify the number of doses of a thrombopoietin receptor agonist therapeutic. The contract modification increased total funded value by approximately $60 million, from $713.9 million to $773.9 million, with a ceiling value of $916.7 million. The period of...
- This contract was awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Amgen USA Inc., a subsidiary of Amgen Inc., to provide a colony stimulating factor (G-CSF or GM-CSF) as a medical countermeasure for mitigating neutropenia arising from exposure to ionizing radiation. The contract is a $154,445,489.12 firm fixed price delivery order under the HHS Colony Stimulating Factor 2013-2018 indefinite delivery contract. The award...
- Pacific Immunology has been awarded a $19,813 purchase order contract by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to provide antibody production testing services in support of the agency's biomedical research efforts. The firm fixed price contract runs from September 2023 through September 2024 and will be performed in Ramona, California. No subcontractors or set aside designations were identified. This award...
- The Uniformed Services University of the Health Sciences (USUHS) Armed Forces Radiobiology Research Institute (AFRRI) awarded a $1.86M firm fixed-price purchase order to Elekta Inc. on September 18, 2025, for the procurement and installation of a replacement clinical linear accelerator (LINAC) system. The contract, which contains no set-aside designation, encompasses a complete turnkey solution including equipment delivery, installation, commissioning, onsite training, warranty coverage, and...
- This is a federal contract award to Amgen USA Inc., a division of the biotechnology company Amgen, by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response. The contract, valued at $37,675,456.54, is for the acquisition of a colony stimulating factor, either G-CSF or GM-CSF, to mitigate neutropenia arising from exposure to ionizing radiation. This is a delivery order contract under the HHS Colony Stimulating Factor 2013-2018 IDIQ contract, a...
- The National Cancer Institute (NCI) awarded a $766,949 firm fixed-price delivery order to GU Rnpts Rmiech, a Belarus-based foreign government entity specializing in radiation health research, on March 15, 2024. This delivery order, with an ultimate completion date of February 14, 2027, supports epidemiological research examining health effects and radiation dosimetry in two distinct cohorts: individuals exposed in utero to Chernobyl fallout and women exposed during lactation. The contract...
- Pacific Immunology, a specialized biotech firm based in Ramona, California, received a $3,687.05 firm fixed-price purchase order from a civilian federal agency (Pacific West Area) for immunological research services. The contract, awarded on July 31, 2019, with an ultimate completion date of August 30, 2019, encompasses multiple deliverables including immunograde peptide synthesis ($580.00), exsanguination bleeds for rabbits ($120.00), and rabbit procurement ($2,990.00), with a volume discount...
- This federal contract award to Innovation Pathways, LLC, a for-profit limited liability company, is for the pharmacological development of IPW-5371 fumarate as a radiation medical countermeasure for the treatment of delayed radiation lung injury under the FDA Animal Rule. The $3,499,688.00 cost-plus-fixed-fee contract was awarded by the National Institute of Allergy and Infectious Diseases, a civilian agency, and has no set-aside designation. The contract work supports research and development...
- This $540,200 cost-plus-fixed-fee grant was awarded by the National Aeronautics and Space Administration Shared Services Center to New York Medical College, a subsidiary of Touro University, to study the long-term consequences of cosmic radiation exposure. Over the three-year period of performance ending January 2023, the contractor will evaluate the impact of heavy ion radiation like iron-56 and protons on cardiovascular function and identify pathways that lead to radiation-induced...
- Siemens Healthcare Diagnostics Inc., a subsidiary of global technology conglomerate Siemens AG, was awarded a $6,615 firm fixed-price purchase order for an IMMULITE 1000 service agreement by the Plains Area civilian federal agency. The contract, awarded on December 19, 2016, with an ultimate completion date of December 13, 2017, carries no set-aside designation and represents a full and open competitive award. Work will be performed in Riverwoods, Illinois. The IMMULITE 1000 is an automated...
INFLUENCE OF LATE RADIATION EFFECTS ON THE IMMUNOLOGIC PARAMETERS OF AGI
Posted 9/23/77
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| A007 | Supplemental Agreement for work within scope | $120.0k | 9/20/82 | |
| A006 | Supplemental Agreement for work within scope | $120.0k | 6/10/82 | |
| A005 | Other Administrative Action | $120.0k | 9/15/81 | |
| A004 | Other Administrative Action | $222.0k | 9/26/80 | |
| A003 | Other Administrative Action | $240.0k | 9/26/79 |